{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:54:03Z","timestamp":1793235243820,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.heliyon.2023.e23083","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T20:34:28Z","timestamp":1701376468000},"page":"e23083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical and pharmacokinetics overview of intranasal administration of fentanyl"],"prefix":"10.1016","volume":"9","author":[{"given":"Samaneh","family":"Nakhaee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0117-872X","authenticated-orcid":false,"given":"Farhad","family":"Saeedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Mehrpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2023.e23083_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s13346-012-0078-y","article-title":"Nasal delivery of fentanyl","volume":"3","author":"Watts","year":"2013","journal-title":"Drug delivery and translational research"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23083_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12016-013-8373-z","article-title":"The effects of opioids on the lung","volume":"46","author":"Radke","year":"2014","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23083_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1358\/dot.2012.48.2.1745275","article-title":"New formulations of fentanyl for acute pain management","volume":"48","author":"Paech","year":"2012","journal-title":"Drugs Today"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e23083_bib4","first-page":"3639","article-title":"Intranasal therapy with opioids for children and adolescents with cancer: results from clinical studies","volume":"27","author":"Triarico","year":"2019","journal-title":"Support. Care Cancer : official journal of the Multinational Association of Supportive Care in Cancer"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e23083_bib5","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.ajem.2019.158483","article-title":"Atomized intranasal vs intravenous fentanyl in severe renal colic pain management: a randomized single-blinded clinical trial","volume":"38","author":"Nazemian","year":"2020","journal-title":"Am. J. Emerg. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23083_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ajem.2019.05.049","article-title":"Comparing intranasal ketamine with intravenous fentanyl in reducing pain in patients with renal colic: a double-blind randomized clinical trial","volume":"38","author":"Mozafari","year":"2020","journal-title":"Am. J. Emerg. Med."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e23083_bib7","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1345\/aph.1R069","article-title":"Intranasal fentanyl spray: a novel dosage form for the treatment of breakthrough cancer pain","volume":"46","author":"Dietrich","year":"2012","journal-title":"Ann. Pharmacother."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23083_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/0018578719828335","article-title":"Intranasal fentanyl use in neonates","volume":"55","author":"Kaushal","year":"2020","journal-title":"Hosp. Pharm."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23083_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40262-012-0016-7","article-title":"Pharmacokinetics of non-intravenous formulations of fentanyl","volume":"52","author":"L\u00f6tsch","year":"2013","journal-title":"Clin. Pharmacokinet."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e23083_bib10","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1185\/03007995.2012.735227","article-title":"A review of the pharmacokinetic profile of transmucosal fentanyl formulations","volume":"28","author":"Moore","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23083_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s13346-012-0078-y","article-title":"Nasal delivery of fentanyl","volume":"3","author":"Watts","year":"2013","journal-title":"Drug delivery and translational research"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23083_bib12","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s40263-022-00930-4","article-title":"Using the intranasal route to administer drugs to treat neurological and psychiatric illnesses: rationale, successes, and future needs","volume":"36","author":"Lofts","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.heliyon.2023.e23083_bib13","series-title":"Role of Intranasal Fentanyl in Breakthrough Pain Management in Cancer Patients","first-page":"225","author":"Leppert","year":"2010"},{"key":"10.1016\/j.heliyon.2023.e23083_bib14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s40265-017-0727-z","article-title":"Fentanyl formulations in the management of pain: an update","volume":"77","author":"Schug","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.heliyon.2023.e23083_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40262-012-0016-7","article-title":"Pharmacokinetics of non-intravenous formulations of fentanyl","volume":"52","author":"L\u00f6tsch","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.heliyon.2023.e23083_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/PPA.S7665","article-title":"Intranasal fentanyl for pain control: current status with a focus on patient considerations","author":"Prommer","year":"2011","journal-title":"Patient Prefer. Adherence"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e23083_bib17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1046\/j.1365-2044.2003.03286.x","article-title":"A new formulation of nasal fentanyl spray for postoperative analgesia: a pilot study","volume":"58","author":"Paech","year":"2003","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23083_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jppr200333159","article-title":"Pharmacokinetics of nasal fentanyl","volume":"33","author":"Lim","year":"2003","journal-title":"J. Pharm. Pract. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23083_bib19","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1136\/ejhpharm-2016-001127","article-title":"Rapid acting fentanyl formulations in breakthrough pain in cancer. Drug selection by means of the System of Objectified Judgement Analysis","volume":"25","author":"Janknegt","year":"2018","journal-title":"Eur. J. Hosp. Pharm."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23083_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3233\/NPM-17149","article-title":"Intranasal midazolam and fentanyl for procedural sedation and analgesia in infants in the neonatal intensive care unit","volume":"12","author":"Ku","year":"2019","journal-title":"J. Neonatal Perinat. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23083_bib21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.clinthera.2008.03.001","article-title":"Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: a randomized, double-blind, double-dummy, two-way, crossover study","volume":"30","author":"Christrup","year":"2008","journal-title":"Clin. Therapeut."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23083_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/ecp.12.69","article-title":"Fentanyl pectin nasal spray: a novel intranasal delivery method for the treatment of breakthrough cancer pain","volume":"6","author":"Bulloch","year":"2013","journal-title":"Expet Rev. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e23083_bib23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5414\/CP201729","article-title":"Single-dose and multi-dose delivery systems for intranasal fentanyl spray are bioequivalent as demonstrated in a replicate pharmacokinetic study","volume":"50","author":"Nave","year":"2012","journal-title":"Int. J. Clin. Pharmacol. Therapeut."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e23083_bib24","doi-asserted-by":"crossref","first-page":"860","DOI":"10.5414\/CPP48860","article-title":"Pharmacokinetics and relative bioavailability of fentanyl pectin nasal spray 100-800 \u03bcg in healthy volunteers","volume":"48","author":"Fisher","year":"2010","journal-title":"Int. J. Clin. Pharmacol. Therapeut."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e23083_bib25","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1345\/aph.1L168","article-title":"Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery","volume":"42","author":"Foster","year":"2008","journal-title":"Ann. Pharmacother."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23083_bib26","first-page":"617","article-title":"C C. Fentanyl Pectin Nasal Spray reduces breakthrough cancer pain intensity compared with placebo in people taking at least 60 mg daily oral morphine or equivalent","volume":"14","year":"2011","journal-title":"Evid. Base Nurs."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23083_bib27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/11207470-000000000-00000","article-title":"Fentanyl pectin nasal spray: in breakthrough pain in opioid-tolerant adults with cancer","volume":"25","author":"Lyseng-Williamson","year":"2011","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23083_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1517\/17425240902939135","article-title":"PecSys: in situ gelling system for optimised nasal drug delivery","volume":"6","author":"Watts","year":"2009","journal-title":"Expet Opin. Drug Deliv."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23083_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235461","article-title":"Intranasal fentanyl spray versus intravenous opioids for the treatment of severe pain in patients with cancer in the emergency department setting: a randomized controlled trial","volume":"15","author":"Banala","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e23083_bib30","unstructured":"Zeppetella G, Davies AN. Opioids for the Management of Breakthrough Pain in Cancer Patients. (1469-493X (Electronic)).."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23083_bib31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/15360288.2015.1047554","article-title":"Efficacy and safety of oral or nasal fentanyl for treatment of breakthrough pain in cancer patients: a systematic review","volume":"29","author":"Rogr\u00edguez","year":"2015","journal-title":"J. Pain Palliat. Care Pharmacother."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e23083_bib32","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1185\/03007990903336135","article-title":"A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial","volume":"25","author":"Mercadante","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23083_bib33","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.clinthera.2009.05.022","volume":"31","author":"Kress","year":"2009","journal-title":"Clin. Therapeut."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23083_bib34","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jpainsymman.2013.07.012","article-title":"A report on the long-term use of fentanyl pectin nasal spray in patients with recurrent breakthrough pain","volume":"47","author":"Taylor","year":"2014","journal-title":"J. Pain Symptom Manag."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23083_bib35","first-page":"565","article-title":"Long-term tolerability, efficacy and acceptability of fentanyl pectin nasal spray for breakthrough cancer pain","volume":"20","author":"Radbruch","year":"2012","journal-title":"Support. Care Cancer : official journal of the Multinational Association of Supportive Care in Cancer"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23083_bib36","first-page":"1349","article-title":"Long-term efficacy and tolerability of intranasal fentanyl in the treatment of breakthrough cancer pain","volume":"23","author":"Mercadante","year":"2015","journal-title":"Support. Care Cancer : official journal of the Multinational Association of Supportive Care in Cancer"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23083_bib37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.clinthera.2008.03.001","article-title":"Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: a randomized, double-blind, double-dummy, two-way, crossover study","volume":"30","author":"Christrup","year":"2008","journal-title":"Clin. Therapeut."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23083_bib38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.annemergmed.2013.10.025","article-title":"Safety of intranasal fentanyl in the out-of-hospital setting: a prospective observational study","volume":"63","author":"Karlsen","year":"2014","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.heliyon.2023.e23083_bib39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.11604\/pamj.2015.20.407.6010","article-title":"Does intranasal fentanyl provide efficient analgesia for renal colic in adults?","volume":"20","author":"Belkouch","year":"2015","journal-title":"The Pan African medical journal"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23083_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1742-6723.2010.01257.x","article-title":"Does the standard intravenous solution of fentanyl (50 microg\/mL) administered intranasally have analgesic efficacy?","volume":"22","author":"Crellin","year":"2010","journal-title":"Emerg. Med. Australasia (EMA) : Emerg. Med. Australasia (EMA)"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e23083_bib41","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1093\/pch\/pxy060","article-title":"A cohort study of intranasal fentanyl for procedural pain management in neonates","volume":"23","author":"McNair","year":"2018","journal-title":"Paediatr. Child Health"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23083_bib42","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1080\/10903127.2019.1704323","article-title":"Intranasal fentanyl versus subcutaneous fentanyl for pain management in prehospital patients with acute pain: a retrospective analysis","volume":"24","author":"Tanguay","year":"2020","journal-title":"Prehosp. Emerg. Care"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e23083_bib43","doi-asserted-by":"crossref","first-page":"860","DOI":"10.5414\/CPP48860","article-title":"Pharmacokinetics and relative bioavailability of fentanyl pectin nasal spray 100 - 800 \u03bcg in healthy volunteers","volume":"48","author":"Fisher","year":"2010","journal-title":"Int. J. Clin. Pharmacol. Therapeut."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23083_bib44","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5414\/CPP48138","article-title":"Pharmacokinetic comparisons of three nasal fentanyl formulations; pectin, chitosan and chitosan-poloxamer 188","volume":"48","author":"Fisher","year":"2010","journal-title":"Int. J. Clin. Pharmacol. Therapeut."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23083_bib45","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.burns.2005.05.001","article-title":"Intranasal fentanyl is an equivalent analgesic to oral morphine in paediatric burns patients for dressing changes: a randomised double blind crossover study","volume":"31","author":"Borland","year":"2005","journal-title":"Burns : journal of the International Society for Burn Injuries"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23083_bib46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.annemergmed.2006.06.016","article-title":"A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department","volume":"49","author":"Borland","year":"2007","journal-title":"Ann. Emerg. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23083_bib47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jpainsymman.2012.07.009","article-title":"Intranasal fentanyl in the palliative care of newborns and infants","volume":"46","author":"Harlos","year":"2013","journal-title":"J. Pain Symptom Manag."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23083_bib48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5055\/jom.2010.0029","article-title":"Long-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray for breakthrough cancer pain in opioid-tolerant patients","volume":"6","author":"Portenoy","year":"2010","journal-title":"Journal of opioid management"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23083_bib49","first-page":"907","article-title":"Intranasal fentanyl for intervention-associated breakthrough pain after cardiac surgery","volume":"60","author":"Valtola","year":"2021"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23083_bib50","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.clinthera.2014.12.010","article-title":"Efficacy and tolerability of intranasal fentanyl spray in cancer patients with breakthrough pain","volume":"37","author":"Thron\u00e6s","year":"2015","journal-title":"Clin. Therapeut."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23083_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5055\/jom.2010.0001","article-title":"Pharmacokinetics of intranasal fentanyl spray in patients with cancer and breakthrough pain","volume":"6","author":"Kaasa","year":"2010","journal-title":"Journal of opioid management"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23083_bib52","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jpain.2014.02.002","article-title":"Intranasal fentanyl versus fentanyl pectin nasal spray for the management of breakthrough cancer pain in doses proportional to basal opioid regimen","volume":"15","author":"Mercadante","year":"2014","journal-title":"J. Pain"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23083_bib53","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/10717544.2012.762435","article-title":"Faster absorption and higher systemic bioavailability of intranasal fentanyl spray compared to oral transmucosal fentanyl citrate in healthy subjects","volume":"20","author":"Nave","year":"2013","journal-title":"Drug Deliv."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23083_bib54","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5414\/CPP48138","article-title":"Pharmacokinetic comparisons of three nasal fentanyl formulations; pectin, chitosan and chitosan-poloxamer 188","volume":"48","author":"Fisher","year":"2010","journal-title":"Int. J. Clin. Pharmacol. Therapeut."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e23083_bib55","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1046\/j.1365-2044.2003.03286.x","article-title":"A new formulation of nasal fentanyl spray for postoperative analgesia: a pilot study","volume":"58","author":"Paech","year":"2003","journal-title":"Anaesthesia"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402310291X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402310291X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:17:02Z","timestamp":1774952222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402310291X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S240584402310291X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23083","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and pharmacokinetics overview of intranasal administration of fentanyl","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e23083"}}